Showing results (191-200 of 2,345) with videos related to
Sort By:
Pageof 235
The AAPS Journal|June 3, 2018
Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized MiceShin-Ichiro Nitta, Mari Hashimoto, Yasuhiro Kazuki, et al.The AAPS Journal|June 3, 2018
Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory CapacityRui Zhang, Jake S Kramer, Josiah D Smith, et al.The AAPS Journal|July 21, 2018
Implementing Optimal Designs for Dose-Response Studies Through Adaptive Randomization for a Small Population GroupYevgen Ryeznik, Oleksandr Sverdlov, Andrew C HookerThe AAPS Journal|May 19, 2017
Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus MonkeysJian-Ming Gu, Xiao-Yan Zhao, Thomas Schwarz, et al.The AAPS Journal|May 19, 2017
Evolution of Choice of Solubility and Dissolution Media After Two Decades of Biopharmaceutical Classification SystemNadia Bou-Chacra, Katherine Jasmine Curo Melo, Ivan Andrés Cordova Morales, et al.The AAPS Journal|May 26, 2018
The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral AdministrationAlexandros Kourentas, Maria Vertzoni, Vicky Barmpatsalou, et al.The AAPS Journal|September 23, 2016
Bone Regeneration Using Gene-Activated MatricesSheetal D'Mello, Keerthi Atluri, Sean M Geary, et al.The AAPS Journal|April 11, 2018
Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary ReportAndreas Abend, Tycho Heimbach, Michael Cohen, et al.The AAPS Journal|July 8, 2017
Pharmacokinetics and Pharmacogenomics of Bupropion in Three Different Formulations with Different Release Kinetics in Healthy Human VolunteersJamie N Connarn, Stephanie Flowers, Marisa Kelly, et al.The AAPS Journal|April 27, 2017
Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing StrategiesJessica Wojciechowski, Richard N Upton, Diane R Mould, et al.Pageof 235